A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of AZD9898

Summary

In this integrated, multi-part, Phase I study, the safety, tolerability, food effect, pharmacokinetic (PK) and pharmacodynamic (PD) properties of single and repeated doses of AZD9898 will be investigated.

Timeline

Start

2017-05-10

Primary completion

2017-08-23

Completion

2017-08-23

Outcome

Outcome not reported

Stopped: “Terminated based on interim review”

Drugs

Indications